Compare Deere & Company (DE) vs UnitedHealth Group Inc (UNH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Deere & Company vs UnitedHealth Group Inc — how do they compare? Deere & Company trades at $620.93 (market cap $175.95B), while UnitedHealth Group Inc trades at $379.3 (market cap $332.96B). The key difference: UnitedHealth Group Inc is the larger of the two by market cap, and UnitedHealth Group Inc pays the higher dividend (2.5%). Which is the better fit depends on your goals — on Pluang, investors hold Deere & Company for 75 Days and UnitedHealth Group Inc for 97 Days on average.
| DE | UNH | |
|---|---|---|
Market Cap | $175.95B | $332.96B |
Volume | 1,387,231 | 7,273,749 |
Sector | Industrials | Health |
52-Week High | $709.48 | $436.35 |
52-Week Low | $439.11 | $259.02 |
Typical Hold Time | 75 Days | 97 Days |
Enterprise Value | $229.85B | $374.82B |
Dividend Yield | 0.99% | 2.5% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Deere & Company (DE) trades at $652.58, down 0.65% on the day, with technical indicators showing a bearish trend despite recent earnings beats. The stock faces cyclical headwinds as agricultural equipment demand softens, with revenue declining from $60.2B in 2023 to $44.7B in 2025. However, strong profitability metrics including 10.39% net margin and 18.4% ROE demonstrate operational resilience. Recent news highlights Deere's AI initiatives to boost farm efficiency and reverse sales trends.
While near-term agricultural cycle pressures persist, Deere's dominant market position and technological innovation provide long-term upside potential. The consensus price target of $731.20 suggests 12% upside, but investors should monitor equipment demand recovery and margin sustainability. Key risks include farm income volatility and elevated debt levels at 60.31% of assets.
UnitedHealth Group (UNH) trades at $370.95, down 1.34% on the day, amid a bearish technical signal from moving averages. The company reported strong Q2 2026 earnings, beating estimates with EPS of $6.38 versus $4.91 expected, and raised full-year guidance. Revenue for 2025 reached $447.57 billion, though net income margin declined to 2.69%. Analyst consensus remains strongly bullish with an 82.69% buy rating and a $470.11 price target, suggesting significant upside from current levels.
UNH presents a compelling investment case driven by earnings beats, raised 2026 outlook, and strategic initiatives like AI investment in Optum. Key risks include regulatory pressures in healthcare, volatility from Medicare Advantage plan changes, and margin compression. The stock's valuation at a P/E of 23.84 appears reasonable given growth prospects, but investors should weigh execution risks against the positive analyst sentiment and institutional backing.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Deere & Company
Deere is the world's leading manufacturer of agricultural equipment, producing some of the most recognizable machines in the heavy machinery industry. The company is divided into four reportable segments: production and precision agriculture, small agriculture and turf, construction and forestry, and John Deere Capital. Its products are available through an extensive dealer network, which includes over 1,900 dealer locations in North America and approximately 3,700 locations globally. John Deere Capital provides retail financing for machinery to its customers, in addition to wholesale financing for dealers, which increases the likelihood of Deere product sales.
Read more on DE →About UnitedHealth Group Inc
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →
